PETALING JAYA: The necessity for a booster jab to counter Covid-19 remains a huge debate even within the global community.
Just two days ago, pharmaceutical company Pfizer said it would be seeking authorisation from regulators for a third booster dose of its vaccine in order to increase its efficacy against the Delta variant.
